"Behind the Buzz" Show: Pharmadrug Inc. (CSE: BUZZ) CEO Daniel Cohen | Financial Buzz

“Behind the Buzz” Show: Pharmadrug Inc. (CSE: BUZZ) CEO Daniel Cohen

FinancialBuzz.com’s latest Behind the Buzz Show: Pharmadrug Inc. CEO Daniel Cohen

Pharmadrug Inc. (CSE: BUZZ) is a German medical cannabis distributor with a Schedule I European Union narcotics license allowing for the importation and distribution of medical cannabis in Germany and throughout the EU.

Daniel Cohen has over 20 years of capital markets experience, most recently spending several years as Head of Sales at Beacon Securities. During this time, Daniel successfully financed many public cannabis companies.

The Extraordinary Future Conference covers today’s most important developments and disruptive headlines in science, technology and culture so investors can position themselves accordingly.  We analyze all industries, and discover what is next in the pipeline, so we can showcase the most impactful trends and changes coming our way.  Rapid change is the norm. It is up to us to position ourselves accordingly, and profit when opportunities arise.

For more information, please visit: Pharmadrug Inc.

About Behind the Buzz: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.

2 Comments